A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

BACKGROUND: A major perspective for the use of circulating tumor DNA (ctDNA) in the clinical setting of non-small cell lung cancer (NSCLC) is expected as predictive factor for resistance and response to EGFR TKI therapy and, especially, as a non-invasive alternative to tissue biopsy. However, ctDNA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Jensen, Steffen Grann, Epistolio, Samantha, Madsen, Cesilie Lind, Kyneb, Majbritt Hauge, Riva, Alice, Paganotti, Alessia, Barizzi, Jessica, Petersen, Rasmus Koefoed, Børgesen, Michael, Molinari, Francesca, Boldorini, Renzo, Lorenzen, Jan, Sørensen, Erik, Christensen, Ulf Bech, Høgdall, Estrid, Frattini, Milo
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8224962/
https://ncbi.nlm.nih.gov/pubmed/34166445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados